Can Radionuclide Therapy be the Solution for Hepatitis B Virus Infection?
作者信息
Sung Pil Soo, Yoo Ie Ryung
机构信息
Division of Hepatology, Department of Internal Medicine, Seoul St. Mary's Hospital, The Catholic University Liver Research Center, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
Division of Nuclear Medicine, Department of Radiology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, 222 Banpo-daero, Seocho-gu, Seoul, 06591 Republic of Korea.
出版信息
Nucl Med Mol Imaging. 2024 Aug;58(5):255-257. doi: 10.1007/s13139-024-00862-5. Epub 2024 May 29.
Abstract
摘要
相似文献
1
Can Radionuclide Therapy be the Solution for Hepatitis B Virus Infection?放射性核素疗法能成为治疗乙型肝炎病毒感染的解决方案吗？
Nucl Med Mol Imaging. 2024 Aug;58(5):255-257. doi: 10.1007/s13139-024-00862-5. Epub 2024 May 29.
2
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection.EASL 2017 临床实践指南：乙型肝炎病毒感染管理。
J Hepatol. 2017 Aug;67(2):370-398. doi: 10.1016/j.jhep.2017.03.021. Epub 2017 Apr 18.
3
Phyllanthus species versus antiviral drugs for chronic hepatitis B virus infection.叶下珠属植物与抗病毒药物治疗慢性乙型肝炎病毒感染的比较
Cochrane Database Syst Rev. 2013 Apr 30;2013(4):CD009004. doi: 10.1002/14651858.CD009004.pub2.
4
Transmission of Hepatitis B and C Virus Infection Through Body Piercing: A Systematic Review and Meta-Analysis.通过人体穿孔传播乙型和丙型肝炎病毒感染：一项系统评价和荟萃分析。
Medicine (Baltimore). 2015 Nov;94(47):e1893. doi: 10.1097/MD.0000000000001893.
5
Real-world Prevalence of Hepatitis B Reactivation in Patients With Resolved Hepatitis B Receiving Rituximab and Non-rituximab-based Immunosuppressive Therapy Without Chemoprophylaxis.在接受利妥昔单抗和非利妥昔单抗为基础的免疫抑制治疗且未进行化学预防的乙肝已康复患者中，乙肝再激活的真实世界患病率。
J Clin Exp Hepatol. 2025 Jul-Aug;15(4):102551. doi: 10.1016/j.jceh.2025.102551. Epub 2025 Mar 21.
6
AGA Clinical Practice Guideline on the Prevention and Treatment of Hepatitis B Virus Reactivation in At-Risk Individuals.美国胃肠病学会关于高危个体乙型肝炎病毒再激活预防与治疗的临床实践指南。
Gastroenterology. 2025 Feb;168(2):267-284. doi: 10.1053/j.gastro.2024.11.008.
7
Prevalence, Risk Factors, and Clinical Profiles of Hepatitis D Virus in Nigeria: A Systematic Review, 2009-2024.尼日利亚丁型肝炎病毒的流行率、危险因素及临床特征：一项2009 - 2024年的系统综述
Viruses. 2024 Oct 31;16(11):1723. doi: 10.3390/v16111723.
8
Hepatitis B surface antigen is upregulated by HIV Tat in an HIV-hepatitis B virus co-infection model system.在HIV-乙肝病毒共感染模型系统中，乙肝表面抗原由HIV反式激活蛋白上调。
Microbiol Spectr. 2025 Jul 23:e0080925. doi: 10.1128/spectrum.00809-25.
9
Hepatitis B immunoglobulin during pregnancy for prevention of mother-to-child transmission of hepatitis B virus.孕期使用乙型肝炎免疫球蛋白预防乙肝病毒母婴传播。
Cochrane Database Syst Rev. 2017 Feb 11;2(2):CD008545. doi: 10.1002/14651858.CD008545.pub2.
10
NIH Consensus Statement on Management of Hepatitis C: 2002.美国国立卫生研究院关于丙型肝炎管理的共识声明：2002年。
NIH Consens State Sci Statements. 2002;19(3):1-46.
本文引用的文献
1
CRISPR/Cas9 for hepatitis B virus infection treatment.CRISPR/Cas9 用于乙型肝炎病毒感染的治疗。
Immun Inflamm Dis. 2023 May;11(5):e866. doi: 10.1002/iid3.866.
2
Global burden of liver disease: 2023 update.全球肝病负担：2023 年更新。
J Hepatol. 2023 Aug;79(2):516-537. doi: 10.1016/j.jhep.2023.03.017. Epub 2023 Mar 27.
3
Discovery of a first-in-class orally available HBV cccDNA inhibitor.发现一种一流的口服可用乙肝cccDNA抑制剂。
J Hepatol. 2023 Apr;78(4):742-753. doi: 10.1016/j.jhep.2022.12.014. Epub 2022 Dec 30.
4
RNA interference as a novel treatment strategy for chronic hepatitis B infection.RNA 干扰作为慢性乙型肝炎感染的一种新的治疗策略。
Clin Mol Hepatol. 2022 Jul;28(3):408-424. doi: 10.3350/cmh.2022.0012. Epub 2022 Feb 17.
5
Covalently closed circular DNA: The ultimate therapeutic target for curing HBV infections.共价闭合环状 DNA：治愈乙型肝炎病毒感染的终极治疗靶点。
J Hepatol. 2021 Sep;75(3):706-717. doi: 10.1016/j.jhep.2021.05.013. Epub 2021 May 26.
6
Auger electrons for cancer therapy - a review.用于癌症治疗的俄歇电子——综述
EJNMMI Radiopharm Chem. 2019 Oct 11;4(1):27. doi: 10.1186/s41181-019-0075-2.
7
DNA damage produced by 125I-triplex-forming oligonucleotides as a measure of their successful delivery into cell nuclei.由125I三链形成寡核苷酸产生的DNA损伤作为其成功递送至细胞核的一种衡量指标。
Ann N Y Acad Sci. 2005 Nov;1058:140-50. doi: 10.1196/annals.1359.022.
8
Radionuclide therapy with iodine-125 and other auger-electron-emitting radionuclides: experimental models and clinical applications.碘-125及其他发射俄歇电子的放射性核素的放射性核素治疗：实验模型与临床应用
Cancer Biother Radiopharm. 2003 Dec;18(6):861-77. doi: 10.1089/108497803322702833.
9
Antigene radiotherapy: targeted radiodamage with 125i-labeled triplex-forming oligonucleotides.反基因放射疗法：用125I标记的三链形成寡核苷酸进行靶向放射损伤
Ann N Y Acad Sci. 2003 Dec;1002:134-40. doi: 10.1196/annals.1281.012.
10
Entecavir is superior to lamivudine in reducing hepatitis B virus DNA in patients with chronic hepatitis B infection.在降低慢性乙型肝炎感染患者的乙肝病毒DNA方面，恩替卡韦优于拉米夫定。
Gastroenterology. 2002 Dec;123(6):1831-8. doi: 10.1053/gast.2002.37058.
Zotero 插件